http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-02059314-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_56921a32710ff6d32a29abd4e3159da6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fa946e8a628dd60dd4793f85732fafea |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4748 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12 |
| filingDate | 2001-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3722f254babeea01107e58898213112d |
| publicationDate | 2002-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-02059314-A2 |
| titleOfInvention | A human melanoma associated antigen and uses therefor |
| abstract | The invention provides isolated nucleic acids molecules, designated 52020 nucleic acid molecules, which encode novel MAGE family members. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing 52020 nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a 52020 gene has been introduced or disrupted. The invention still further provides isolated 52020 proteins, fusion proteins, antigenic peptides and anti-52020 antibodies. Diagnostic methods utilizing compositions of the invention are also provided. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006119527-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03025228-A1 |
| priorityDate | 2000-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 772.